Back to Results
First PageMeta Content
Financial regulation / International Financial Reporting Standards / RNPV / Net asset value / Radiation therapy / Medicine / Radiation oncology / Medical physics


Nanobiotix Positive clinical data Giant leap forward from initial small steps
Add to Reading List

Document Date: 2013-06-13 02:15:24

Open Document

File Size: 448,44 KB

Share Result on Facebook

City

Berlin / Wellington / Chicago / London / /

Company

FTSE International Limited / Nanobiotix / London Stock Exchange Group / Edison Group / PharmaEngine / Edison Investment Research Limited / /

Continent

Asia / Europe / /

Country

United States / New Zealand / /

Currency

USD / EUR / /

/

Event

FDA Phase / Company Listing Change / /

IndustryTerm

treatment of cancer / imaging / /

MarketIndex

FTSE 100 / /

MedicalCondition

necrosis / liposarcoma / cancer / tumour necrosis / percentage necrosis / soft tissue sarcoma / tumour / liver cancers / large tumours NBTXR3 / head and neck cancer / percent necrosis / /

MedicalTreatment

radiotherapy / surgery / /

Organization

Federal Aviation Administration / American Society of Clinical Oncology / /

Person

Martinez SR / Philippa Gardner / /

/

Position

liver cancer Head / lead candidate selection Initial head / RT / /

Product

Asia Phase I / Q213 / Asia-Pacific / H213 / Europe / /

Region

Asia-Pacific / /

Technology

MRI / /

SocialTag